Milk-based drug may reduce lung cancer risk

The researchers at the University of Colorado, Denver have concluded a study on Silibinin, a drug derived from the milk. During the research, they found it wiped out lung cancer in mice.

Dr. Rana P. Singh and the team of the researchers studied on milk components, silymarin and silibinin. They examined their efficiency against different types of cancer in mice.

Silibinin actually reduced the blood vessels that provide nutrients to the tumors and help them to grow. According to Dr. Rana P Singh, the clinical trials with silibinin will be done after ongoing laboratory test. Human trail of silibinin for the treatment of prostate cancer is already going on.


Related Articles

Back to top button